Won, E.-J.; Lee, M.; Lee, E.-K.; Baek, S.-H.; Yoon, T.-J.
Lipid-Based Nanoparticles Fused with Natural Killer Cell Plasma Membrane Proteins for Triple-Negative Breast Cancer Therapy. Pharmaceutics 2024, 16, 1142.
https://doi.org/10.3390/pharmaceutics16091142
AMA Style
Won E-J, Lee M, Lee E-K, Baek S-H, Yoon T-J.
Lipid-Based Nanoparticles Fused with Natural Killer Cell Plasma Membrane Proteins for Triple-Negative Breast Cancer Therapy. Pharmaceutics. 2024; 16(9):1142.
https://doi.org/10.3390/pharmaceutics16091142
Chicago/Turabian Style
Won, Eun-Jeong, Myungchul Lee, Eui-Kyung Lee, Seung-Hoon Baek, and Tae-Jong Yoon.
2024. "Lipid-Based Nanoparticles Fused with Natural Killer Cell Plasma Membrane Proteins for Triple-Negative Breast Cancer Therapy" Pharmaceutics 16, no. 9: 1142.
https://doi.org/10.3390/pharmaceutics16091142
APA Style
Won, E.-J., Lee, M., Lee, E.-K., Baek, S.-H., & Yoon, T.-J.
(2024). Lipid-Based Nanoparticles Fused with Natural Killer Cell Plasma Membrane Proteins for Triple-Negative Breast Cancer Therapy. Pharmaceutics, 16(9), 1142.
https://doi.org/10.3390/pharmaceutics16091142